Sonja Merkesdal
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Intraindividual Comparisons to Determine Comparative Effectiveness: Their Relevance for G-BA's Health Technology Assessments.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: May 09, 2020
Type I Diabetes is the Main Cost Driver in Autoimmune Polyendocrinopathy.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 26, 2019
Pregnancy Related Health Care Needs in Refugees-A Current Three Center Experience in Europe.
Journal: International journal of environmental research and public health
Published: June 30, 2018
Patients With Arthralgia and Anti-Citrullinated Peptide Antibody Positivity on Hydroxychloroquine Therapy: An Update on 2 and 3 Years' Follow-up Data of a Pilot Study.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: June 19, 2018
Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study.
Journal: Infectious diseases and therapy
Published: July 19, 2017
Instruments for Measuring the Effects of Early Intervention on Maintaining and Restoring Ability to Work in Germany: Opinion of an Interdisciplinary Working Group
Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Published: December 24, 2015
Public health relevance of Graves' orbitopathy.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 28, 2012
Interest of modelling in rheumatoid arthritis.
Journal: Clinical and experimental rheumatology
Published: September 14, 2012
Cost-effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 21, 2012
Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany.
Journal: Clinical and experimental rheumatology
Published: June 02, 2012
Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: November 20, 2008
Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components
Journal: Zeitschrift fur Rheumatologie
Published: March 15, 2006
Last Updated: 09/26/2026